Cargando…

Yes‐associated protein activation potentiates glycogen synthase kinase‐3 inhibitor‐induced proliferation of neonatal cardiomyocytes and iPS cell‐derived cardiomyocytes

Because mammalian cardiomyocytes largely cease to proliferate immediately after birth, the regenerative activity of the heart is limited. To date, much effort has been made to clarify the regulatory mechanism of cardiomyocyte proliferation because the amplification of cardiomyocytes could be a promi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kametani, Yusuke, Tanaka, Shota, Wada, Yuriko, Suzuki, Shota, Umeda, Ayaka, Nishinaka, Kosuke, Okada, Yoshiaki, Maeda, Makiko, Miyagawa, Shigeru, Sawa, Yoshiki, Obana, Masanori, Fujio, Yasushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311433/ https://www.ncbi.nlm.nih.gov/pubmed/35312066 http://dx.doi.org/10.1002/jcp.30724

Ejemplares similares

Runx1 is upregulated by STAT3 and promotes proliferation of neonatal rat cardiomyocytes
por: Suzuki, Shota, et al.
Publicado: (2023)

CXCL10 is a novel anti‐angiogenic factor downstream of p53 in cardiomyocytes
por: Wahyuni, Tri, et al.
Publicado: (2022)

Establishment of a protocol to administer immunosuppressive drugs for iPS cell-derived cardiomyocyte patch transplantation in a rat myocardial infarction model
por: Ito, Emiko, et al.
Publicado: (2023)

Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes
por: Inoue, Hiroyuki, et al.
Publicado: (2022)

Engraftment and morphological development of vascularized human iPS cell-derived 3D-cardiomyocyte tissue after xenotransplantation
por: Narita, Hirokazu, et al.
Publicado: (2017)

Adult murine cardiomyocytes exhibit regenerative activity with cell cycle reentry through STAT3 in the healing process of myocarditis
por: Miyawaki, Akimitsu, et al.
Publicado: (2017)

Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model
por: Kawamura, Masashi, et al.
Publicado: (2017)

β2‐adrenergic stimulation induces interleukin‐6 by increasing Arid5a, a stabilizer of mRNA, through cAMP/PKA/CREB pathway in cardiac fibroblasts
por: Tanaka, Shota, et al.
Publicado: (2020)

Natural killer cells impede the engraftment of cardiomyocytes derived from induced pluripotent stem cells in syngeneic mouse model
por: Nakamura, Yuki, et al.
Publicado: (2019)

Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype
por: Yokoyama, Junya, et al.
Publicado: (2021)

Cardiotoxicity assessment using 3D vascularized cardiac tissue consisting of human iPSC-derived cardiomyocytes and fibroblasts
por: Tadano, Kiyoshi, et al.
Publicado: (2021)

Progesterone, via yes‐associated protein, promotes cardiomyocyte proliferation and cardiac repair
por: Lan, Cong, et al.
Publicado: (2020)

The Exciting Realities and Possibilities of iPS-Derived Cardiomyocytes
por: Takahashi, Fuga, et al.
Publicado: (2023)

Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells
por: Yoshida, Shohei, et al.
Publicado: (2018)

Homogeneous 2D and 3D alignment of cardiomyocyte in dilated cardiomyopathy revealed by intravital heart imaging
por: Masuyama, Kiyoshi, et al.
Publicado: (2021)

Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application
por: Ito, Emiko, et al.
Publicado: (2019)

Human-Induced Pluripotent Stem Cell–Derived Cardiomyocyte Model for TNNT2 Δ160E-Induced Cardiomyopathy
por: Kondo, Takumi, et al.
Publicado: (2022)

Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation
por: Yoshida, Shohei, et al.
Publicado: (2020)

N-Glycans: Phenotypic Homology and Structural Differences between Myocardial Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Kawamura, Takuji, et al.
Publicado: (2014)

Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
por: Haq, Syed, et al.
Publicado: (2000)

Publisher Correction: Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation
por: Yoshida, Shohei, et al.
Publicado: (2020)

Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue
por: Iseoka, Hiroko, et al.
Publicado: (2018)

Chimerism through the activation of invariant natural killer T cells prolongs graft survival after transplantation of induced pluripotent stem cell–derived allogeneic cardiomyocytes
por: Yoshida, Shohei, et al.
Publicado: (2022)

Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β
por: Wu, Wei, et al.
Publicado: (2019)

Eliminating residual iPS cells for safety in clinical application
por: Masuda, Shigeo, et al.
Publicado: (2015)

Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates
por: Kawamura, Takuji, et al.
Publicado: (2016)

Electronic cigarette extract induced toxic effect in iPS-derived cardiomyocytes
por: Basma, Hesham, et al.
Publicado: (2020)

Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
por: Miyagawa, Shigeru, et al.
Publicado: (2022)

Micro Vacuum Chuck and Tensile Test System for Bio-Mechanical Evaluation of 3D Tissue Constructed of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPS-CM)
por: Uesugi, Kaoru, et al.
Publicado: (2019)

Decreased YAP activity reduces proliferative ability in human induced pluripotent stem cell of duchenne muscular dystrophy derived cardiomyocytes
por: Yasutake, Hideki, et al.
Publicado: (2021)

Adeno-associated virus-mediated gene delivery promotes S-phase entry-independent precise targeted integration in cardiomyocytes
por: Kohama, Yasuaki, et al.
Publicado: (2020)

Circulating re-entrant waves promote maturation of hiPSC-derived cardiomyocytes in self-organized tissue ring
por: Li, Junjun, et al.
Publicado: (2020)

Transplantation of Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Is Superior to Somatic Stem Cell Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction
por: Ishida, Masaru, et al.
Publicado: (2019)

Revealing potential cardiac manifestation of ADPKD using iPS cell-derived cardiomyocytes
por: Morizane, Ryuji
Publicado: (2019)

Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes
por: Shiba, Mikio, et al.
Publicado: (2021)

Cardiomyocytes fuse with surrounding noncardiomyocytes and reenter the cell cycle
por: Matsuura, Katsuhisa, et al.
Publicado: (2004)

Effect of hydroxychloroquine on proarrhythmia risk assessment using human iPSC-derived cardiomyocytes
por: Yanagida, Shota, et al.
Publicado: (2021)

2-aminoethoxydiphenyl borate provides an anti-oxidative effect and mediates cardioprotection during ischemia reperfusion in mice
por: Morihara, Hirofumi, et al.
Publicado: (2017)

Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports
por: Kawamura, Takuji, et al.
Publicado: (2023)

Activation of the urotensin-II receptor by remdesivir induces cardiomyocyte dysfunction
por: Ogawa, Akiko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1su9lsl374qd0gb46jim0aeob7